Funding for this research was provided by:
Fifth Framework Programme (QLK1-CT-2002-01096)
Agence Nationale de la Recherche (PRIB2005 - PRIONSECUR, ANR-10-BLAN-1330 01, BIOTECS 2010 - BLOODSECUR, ANR-15-CE18-0028)
Health Canada (4500216567)
MacoPharma (CAJ-11-56 2011-13)
Article History
Received: 19 October 2021
Accepted: 21 May 2022
First Online: 4 June 2022
Declarations
:
: This review does not contain any studies with human participants or animals performed by any of the authors that has not been published elsewhere.
: The authors declare no competing interests.